Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ANI PHARMACEUTICALS INC | c98259e10vk.htm |
| EX-4.9 - EXHIBIT 4.9 - ANI PHARMACEUTICALS INC | c98259exv4w9.htm |
| EX-23.1 - EXHIBIT 23.1 - ANI PHARMACEUTICALS INC | c98259exv23w1.htm |
| EX-31.1 - EXHIBIT 31.1 - ANI PHARMACEUTICALS INC | c98259exv31w1.htm |
| EX-32.1 - EXHIBIT 32.1 - ANI PHARMACEUTICALS INC | c98259exv32w1.htm |
| EX-31.2 - EXHIBIT 31.2 - ANI PHARMACEUTICALS INC | c98259exv31w2.htm |
| EX-10.23 - EXHIBIT 10.23 - ANI PHARMACEUTICALS INC | c98259exv10w23.htm |
| EX-10.22 - EXHIBIT 10.22 - ANI PHARMACEUTICALS INC | c98259exv10w22.htm |
| EX-10.39 - EXHIBIT 10.39 - ANI PHARMACEUTICALS INC | c98259exv10w39.htm |
| EX-10.12 - EXHIBIT 10.12 - ANI PHARMACEUTICALS INC | c98259exv10w12.htm |
Exhibit 32.2
Certification of CFO Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
Sarbanes-Oxley Act of 2002
In connection with the Annual Report of BioSante Pharmaceuticals, Inc. (the “Company”) on Form 10-K
for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Phillip B. Donenberg, Chief Financial Officer, Treasurer and
Secretary of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. |
| /s/ Phillip B. Donenberg | ||||
| Phillip B. Donenberg | ||||
| Chief Financial Officer, Treasurer and Secretary March 30, 2010 |
||||